Online citations, reference lists, and bibliographies.
← Back to Search

Reduction Of Pupillary Constriction During Cataract Surgery Using Suprofen.

W. Stark, W. Fagadau, Robert H. Stewart, A. Crandall, J. Defaller, T. A. Reaves, P. Klein
Published 1986 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The efficacy of a new nonsteroidal anti-inflammatory agent, suprofen, for reducing pupillary constriction during cataract surgery was ascertained in a double-masked, multicenter, clinical study. Prior to surgery 1.0% suprofen or a placebo was instilled; the surgeon's normal regimen of mydriatics and cycloplegics was used. Suprofen (209 patients) was far more effective than the placebo (203 patients) in maintaining a dilated pupil prior to intraocular lens (IOL) implantation (or instillation of a miotic). The mean pupillary area prior to IOL implantation was 6.3 sq mm larger (20% larger) in patients treated with suprofen than in patients receiving the placebo. The investigators' subjective evaluations of the adequacy of pupil size for IOL implantation and of the difficulty of IOL implantation favored patients treated with suprofen over those receiving the placebo.
This paper references
Adoptive transfer of immunity to intraocular tumors in mice.
J. Niederkorn (1984)
Prostaglandins and the eye.
P. Es (1975)
10.1016/S0161-6420(82)34693-X
Inhibitors of surgically induced miosis.
R. M. Duffin (1982)
Topical indomethacin in soft cataract aspiration
M. Sawa (1976)
Flurbiprofen and human intraocular inflammation.
Hillman Js (1980)
10.1038/NEWBIO239248A0
Release of prostaglandins in ocular inflammation in the rabbit.
K. Eakins (1972)
10.1111/j.1476-5381.1975.tb07595.x
RELEASE OF PROSTAGLANDIN‐LIKE SUBSTANCES BY SHIGELLA ENDOTOXIN AND ITS INHIBITION BY NON‐STEROIDAL ANTI‐INFLAMMATORY COMPOUNDS
P. Bhattacherjee (1975)
Characterization of chemotactic factors in corneal wound healing.
B. Srinivasan (1980)
10.1001/ARCHOPHT.1985.01050010101028
Effect of suprofen on corneal wound healing.
B. Lee (1985)
Pharmacological and biochemical properties of drug substances
M. E. Goldberg (1977)
Clinical trial of flurbiprofen to maintain pupillary dilation during cataract surgery.
Keates Rh (1984)
10.1136/bjo.67.2.94
Effect of indomethacin in preventing surgically induced miosis.
H. C. Keulen-de Vos (1983)
The effect of topical indomethacin ophthalmic solution in maintaining mydriasis during cataract surgery.
Keates Rh (1984)
10.1159/000265140
Inhibition of Trauma-Induced Miosis by Indoxole
R. Klug (1981)
10.1016/0090-6980(77)90196-4
Microsomal preparations of normal bovine iris-ciliary body generate prostacyclin-like but not thromboxane-A2-activity.
F. S. Kulkarni (1977)
10.1016/0014-4835(81)90008-7
Synthesis of cyclooxygenase products by human anterior uvea from cyclic prostaglandin endoperoxide (PGH2).
P. Kulkarni (1981)



This paper is referenced by
10.1016/j.ajo.2008.07.027
Are topical NSAIDs needed for routine cataract surgery?
Alisa Kim (2008)
10.1097/IAE.0b013e31817b6afa
TOPICAL ADMINISTRATION OF DICLOFENAC (1%) IN THE PREVENTION OF MIOSIS DURING VITRECTOMY
A. Mirshahi (2008)
Noninfectious Causes of Canine Anterior Uveitis
B. Wasik (2010)
10.1016/S0886-3350(13)80013-2
Topical flurbiprofen in extracapsular cataract surgery: Effect on pupillary diameter and iris fluorescein leakage
S. Cillino (1993)
10.1001/ARCHOPHT.1997.01100160289004
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
K. Solomon (1997)
10.1016/S0161-6420(89)32845-4
The effect of treatment with topical nonsteroidal anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery.
H. Gimbel (1989)
10.1016/S0149-2918(00)88323-X
Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Robert H. Stewart (1999)
10.1136/bjo.78.2.95
Intraocular adrenaline maintains mydriasis during cataract surgery.
M. Corbett (1994)
10.3109/02713689009069929
Chronic electrical stimulation of sympathetic nerves: effects on blood-aqueous barrier.
S. P. Bartels (1990)
10.1016/S0955-3681(13)80498-4
Protection Against Pupil Constriction During Cataract Surgery by Ocufen
R. C. Drews (1991)
10.1016/S0142-9612(02)00080-7
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
10.1016/B978-1-4160-0016-7.50027-8
Nonsteroidal Antiinflammatory Drugs
K. To (2008)
10.1016/S0886-3350(13)80413-0
Effects of topical suprofen and flurbiprofen on the miosis produced by anterior chamber irrigation with cholinergic agonists
J. Zimm (1991)
10.1016/S0886-3350(13)80611-6
Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsification
E. Blaydes (1993)
10.1016/S0886-3350(96)80162-3
Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis
C. W. Roberts (1996)
10.1089/108076801750295281
Maintenance of mydriasis with one bolus of epinephrine injection during phacoemulsification.
S. Liou (2001)
10.1016/S0002-9394(14)76781-9
The effect of preoperative flurbiprofen on miosis produced by acetylcholine during cataract surgery.
J. M. Holmes (1991)
10.2165/00003495-200767090-00004
The Role of NSAIDs in the Management of Postoperative Ophthalmic Inflammation
J. Colin (2012)
10.1089/JOP.2013.0244
Effect of topical nonsteroidal anti-inflammatory drugs and nuclear hardness on maintenance of mydriasis during phacoemulsification surgery.
LiuChang (2014)
Comparison of Ketorolac Tromethamine and Prednisolone Acetate in Preventing Surgically Induced Miosis during Cataract Surgery.
Y. M. Suleiman (2010)
10.1038/clpt.1993.57
Industrial publication of controlled clinical trial data
G. Novack (1993)
10.1038/clpt.1993.58
Industrial publication of controlled clinical trial data
D. Goldstein (1993)
10.1016/S0886-3350(99)80009-1
Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.
S. Brint (1999)
10.1038/eye.2000.157
The effect of pre-operative topical flurbiprofen or diclofenac on pupil dilatation
V. T. Thaller (2000)
10.1016/j.jcrs.2010.04.033
Nepafenac‐assisted mydriasis in a rabbit model
M. Yoon (2010)
10.1016/S1060-135X(96)90025-1
Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery.
R. M. Brown (1996)
10.1177/112067210001000209
The Efficacy of 2.5% Phenylephrine and Flurbiprofen Combined in Inducing and Maintaining Pupillary Dilatation during Cataract Surgery
F. Öztürk (2000)
10.1016/S0886-3350(89)80068-9
Ocufen and pupillary dilation during cataract surgery
R. C. Drews (1989)
10.1016/j.jcrs.2018.02.027
Medical and surgical management of the small pupil during cataract surgery.
S. Al-Hashimi (2018)
10.1007/978-3-7091-9074-6_62
Prostaglandinsynthesehemmer zur Vermeidung der intraoperativen induzierten Miosis
M. R. Novak (1990)
10.3109/15569529109052135
Treatment of Postoperative Inflammation in Ophthalmology
A. Flach (1991)
10.1016/0039-6257(92)90095-B
Cyclo-oxygenase inhibitors in ophthalmology.
A. Flach (1992)
See more
Semantic Scholar Logo Some data provided by SemanticScholar